ZB11ALD-S16-5	
    			    			
                EHTJUi005-A-1            
            
        General
| Cell Line | |
| hPSCreg name | EHTJUi005-A-1 | 
| Cite as: | EHTJUi005-A-1 (RRID:CVCL_B0JM) | 
| Alternative name(s) | 
	ZB11ALD-S16-5	 | 
| Cell line type | Human induced pluripotent stem cell (hiPSC) | 
| Similar lines | |
| Last update | 30th August 2021 | 
| User feedback | |
| Provider | |
| Generator | East Hospital Affiliated to Tongji University (EHTJU) | 
| Owner | East Hospital Affiliated to Tongji University (EHTJU) | 
| Distributors | |
| Derivation country | China | 
| External Databases | |
| BioSamples | SAMEA8904410 | 
| Cellosaurus | CVCL_B0JM | 
| Wikidata | Q108820186 | 
| General Information | |
| Publications | |
| * Is the cell line readily obtainable for third parties? | Yes Research use: allowed Clinical use: not allowed Commercial use: allowed | 
| Subclone of | |
Donor Information
| General Donor Information | |
| Sex | female | 
| Ethnicity | Han | 
| Phenotype and Disease related information (Donor) | |
| Diseases | No disease was diagnosed. | 
| Disease associated phenotypes | no phenotypes | 
| Karyotyping (Donor) | |
| Has the donor karyotype been analysed? | No | 
| Other Genotyping (Donor) | |
| Is there genome-wide genotyping or functional data available? | Yes 
										Exome sequencing										
																				
										 Health | 
| External Databases (Donor) | |
| BioSamples | SAMEA8883269 | 
Ethics
Also have a look at the ethics information for the parental line
        				
		
			EHTJUi005-A		
        				.
        			        
        			        			        			        			| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | 
hIPSC Derivation
| General | |
| The source cell information can be found in the parental cell line
						EHTJUi005-A. | |
| Reprogramming method | |
| Vector type | Non-integrating | 
| Vector | Sendai virus | 
| Genes | |
| Is reprogramming vector detectable? | No | 
| Methods used | 
	RT-PCR	 | 
| Vector free reprogramming | |
| Other | |
| Derived under xeno-free conditions | Yes | 
| Derived under GMP? | Yes | 
| Available as clinical grade? | No | 
Culture Conditions
| Surface coating | Laminin | 
| Feeder cells | No | 
| Passage method | Enzyme-free cell dissociation 
											Gentle Cell Dissociation Reagent										 | 
| CO2 Concentration | 5 % | 
| Medium | Other medium: 
			Base medium: stemfit			 Main protein source: Serum concentration: % | 
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | No | 
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No | 
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes | 
Characterisation
Analysis of Undifferentiated Cells
								Self-renewal
							
							Positive
							
								Endoderm
							
							Unknown
							
								Mesoderm
							
							Unknown
							
								Ectoderm score
							
							Unknown
							
						alkaline phosphatase staining						
						Differentiation Potency
In vitro directed differentiation
					| Microbiology / Virus Screening | |
| HIV 1 | Negative | 
| HIV 2 | Negative | 
| Hepatitis B | Negative | 
| Hepatitis C | Negative | 
| Mycoplasma | Negative | 
Genotyping
| Karyotyping (Cell Line) | |
| Has the cell line karyotype been analysed? | Yes 
												46,XX
											 
											Passage number: 26											 
											Karyotyping method:
											G-Banding											
																						 | 
| Other Genotyping (Cell Line) | |
| Is there genome-wide genotyping or functional data available? | Yes 
											Exome sequencing											
																						
    																					
																					 | 
Genetic Modification
| Disease/phenotype related modifications |  | 

Login to share your feedback, experiences or results with the research community.